🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul Severson

RG Biopharma (United States)

ORCID: 0009-0008-6762-6557

Also affiliated with Principia Biopharma (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT”.

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2007
N/A
0.965DataRank · unranked
32 citations

Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang, John H. Healey +19 more

Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma

Antioxidants(2022)10.3390/antiox11020315
N/A
0.505DataRank · unranked
28 citations

Verónica Pérez de la Cruz, Benjamín Pineda, Gustavo Ignacio Vázquez Cervantes, Daniela Ramírez Ortega, David W. Donley +6 more

Targeting BRAF Class II and III Mutations in NSCLC with the pan-RAF inhibitor Exarafenib Reveals ARAF-KSR1-Mediated Resistance and Rational Combination Strategies

Research Square(2025)10.21203/rs.3.rs-5135027/v1
N/A
0DataRank · unranked
0 citations

Tadashi Manabe, Hannah C. Bergo, Qingtian Li, Tim Sen Wang, Paul Severson +19 more